Several analysts have recently updated their ratings and price targets for Synopsys (NASDAQ: SNPS):
- 9/25/2026 – Synopsys was upgraded by Roth Capital to “buy”.
- 9/25/2026 – Synopsys was downgraded by HSBC Holdings plc from “buy” to “reduce”.
- 9/25/2026 – Synopsys was downgraded by KeyCorp from “overweight” to “strong sell”.
- 9/25/2026 – Synopsys is now covered by Sanford C. Bernstein. They set an “outperform” rating on the stock.
- 9/25/2026 – Synopsys is now covered by Barclays PLC. They set an “overweight” rating on the stock.
- 9/25/2026 – Synopsys was upgraded by HSBC Holdings plc from “hold” to “buy”. They now have a $700.00 price target on the stock, up from $490.00.
- 9/24/2026 – Synopsys was upgraded by BNP Paribas Exane from “underperform” to “neutral”. They now have a $420.00 price target on the stock.
- 9/11/2026 – Synopsys was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”.
- 9/10/2026 – Synopsys was upgraded by Wells Fargo & Company from “equal weight” to “overweight”. They now have a $475.00 price target on the stock, up from $450.00.
- 8/27/2026 – Synopsys was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
- 8/27/2026 – Synopsys was given a new $570.00 price target by UBS Group AG.
- 8/27/2026 – Synopsys had its price target lowered by Mizuho from $600.00 to $550.00. They now have an “outperform” rating on the stock.
- 8/27/2026 – Synopsys was upgraded by Robert W. Baird from “neutral” to “outperform”. They now have a $560.00 price target on the stock, up from $558.00.
- 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co.. They now have a $570.00 price target on the stock.
- 8/27/2026 – Synopsys had its “buy” rating reaffirmed by Needham & Company LLC. They now have a $580.00 price target on the stock.
- 8/25/2026 – Synopsys had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $575.00 price target on the stock.
- 8/21/2026 – Synopsys was downgraded by Zacks Research from “strong-buy” to “hold”.
- 8/19/2026 – Synopsys had its “buy” rating reaffirmed by Benchmark Co..
- 8/19/2026 – Synopsys had its price target lowered by Morgan Stanley from $525.00 to $500.00. They now have an “equal weight” rating on the stock.
- 8/19/2026 – Synopsys had its “overweight” rating reaffirmed by KeyCorp.
- 8/11/2026 – Synopsys had its price target lowered by Wells Fargo & Company from $535.00 to $450.00. They now have an “equal weight” rating on the stock.
Insider Buying and Selling
In other news, insider Aart de Geus sold 24,641 shares of Synopsys stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $419.44, for a total transaction of $10,335,421.04. Following the transaction, the insider directly owned 120,443 shares of the company’s stock, valued at $50,518,611.92. The trade was a 16.98% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,604 shares of the company’s stock in a transaction that occurred on Tuesday, September 15th. The stock was sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the completion of the transaction, the chief executive officer owned 76,865 shares of the company’s stock, valued at approximately $28,815,151.20. The trade was a 15.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 89,245 shares of company stock valued at $37,992,919. 0.56% of the stock is owned by corporate insiders.
The company’s offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.
Featured Stories
- Five stocks we like better than Synopsys
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for Synopsys Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys Inc and related companies with MarketBeat.com's FREE daily email newsletter.
